Bio Spec Overview
Ignite Creation Date:
2025-12-25 @ 2:48 AM
Last Modification Date:
2025-12-25 @ 2:48 AM
Retention:
SAMPLES_WITH_DNA
Description:
To minimize trauma for pancreatic disease patients and adhere to ethical requirements, we strictly use residual tissue from the EUS-FNB procedure for microbiome sequencing. During EUS-FNB, we first perform Rapid On-Site Evaluation (ROSE) to preliminarily assess sample quality and suitability. Based on quick pathological evaluation results, appropriate residual tissue is selected for microbiome analysis. This ensures sample quality and maximizes the use of residual tissue from clinical diagnostics, avoiding additional collection and meeting ethical standards. Patients undergo EUS-FNB based solely on clinical necessity, not for research purposes. The retained pancreatic tissue (about one strip) from EUS-FNB will be used for microbiome sequencing.
Section:
To minimize trauma for pancreatic disease patients and adhere to ethical requirements, we strictly use residual tissue from the EUS-FNB procedure for microbiome sequencing. During EUS-FNB, we first perform Rapid On-Site Evaluation (ROSE) to preliminarily assess sample quality and suitability. Based on quick pathological evaluation results, appropriate residual tissue is selected for microbiome analysis. This ensures sample quality and maximizes the use of residual tissue from clinical diagnostics, avoiding additional collection and meeting ethical standards. Patients undergo EUS-FNB based solely on clinical necessity, not for research purposes. The retained pancreatic tissue (about one strip) from EUS-FNB will be used for microbiome sequencing.